808 related articles for article (PubMed ID: 29126301)
1. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
Wun TC
Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
[TBL] [Abstract][Full Text] [Related]
3. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
Ogiwara K; Furukawa S; Shinohara S; Tabuchi Y; Arai N; Noguchi-Sasaki M; Soeda T; Shima M; Nogami K
Haemophilia; 2023 Jan; 29(1):329-335. PubMed ID: 36137299
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.
Tanaka KA; Terada R; Butt AL; Mazzeffi MA; McNeil JS
Anesth Analg; 2023 May; 136(5):894-904. PubMed ID: 37058725
[TBL] [Abstract][Full Text] [Related]
7. Interpreting coagulation mixing study results in the era of direct oral anticoagulants.
Kim MJ; Salazar E; Philips B; Rice L; Castillo B; Leveque C; Chen J
Blood Coagul Fibrinolysis; 2024 Jan; 35(1):23-26. PubMed ID: 37994629
[TBL] [Abstract][Full Text] [Related]
8. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
Santoro RC; Molinari AC; Leotta M; Martini T
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis of bleeding disorders. Basic screening tests.
Palmer RL
Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
[TBL] [Abstract][Full Text] [Related]
10. An overview of hemostasis.
Troy GC
Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):5-20. PubMed ID: 3282384
[TBL] [Abstract][Full Text] [Related]
11. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
Gosselin RC
Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
[TBL] [Abstract][Full Text] [Related]
12. The new oral anticoagulants and the future of haemostasis laboratory testing.
Favaloro EJ; Lippi G
Biochem Med (Zagreb); 2012; 22(3):329-41. PubMed ID: 23092064
[TBL] [Abstract][Full Text] [Related]
13. Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). A clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma.
Doellgast GJ; Triscott MX; Buss DH; West J
Clin Chem; 1988 Feb; 34(2):294-9. PubMed ID: 2830053
[TBL] [Abstract][Full Text] [Related]
14. [Activation of the blood coagulation system during gram-negative infections and endotoxemias].
Lüscher EF
Fortschr Med; 1975 Aug; 93(22-23):1072-6. PubMed ID: 1225791
[TBL] [Abstract][Full Text] [Related]
15. Screening for the lupus anticoagulant.
Triplett DA
Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
[TBL] [Abstract][Full Text] [Related]
17. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.
Mannucci PM; Canciani MT; Mari D; Meucci P
Scand J Haematol; 1979 May; 22(5):423-32. PubMed ID: 472662
[TBL] [Abstract][Full Text] [Related]
18. The influence of von Willebrand factor on factor VIII activity measurements.
Butenas S; Parhami-Seren B; Mann KG
J Thromb Haemost; 2009 Jan; 7(1):132-7. PubMed ID: 18983499
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
